All Articles
By Kimberly Hall Alexander ; Chris Draft ; Renee Martin Anderson; Georgeta Lester ; Kristine Cherol; Ros Miller; Robin Youkilis DiPaolo; Danielle Pardue
The 8 caregivers who took part in this roundtable are from different cities throughout the United States, have unique backgrounds, and experienced different cancer journeys. Although the majority of the participants were focused on lung cancer, they recognized how much they had in common with those caring for loved ones with other diseases. Whether their loved ones are still fighting or have passed on, these individuals are united in their desire for better care and support for people living with cancer and their caregivers. Read More ›
Traveling for people with cancer requires some precautions, but a summer vacation can be a great refresher for your mind and body with just a few extra steps added to your plans! Read More ›
Brigid Wallace contemplates the choices she made when living in the “new normal” after her cancer diagnosis. She describes the struggles and personal victories that tested her faith and strength after she learned she had non-Hodgkin lymphoma. Read More ›
Dennis Golden was an active, fit, 70-year-old when he learned he had prostate cancer. He was surprised to discover that few men know the warning signs and how potentially serious it can be. In response, he formed the National Prostate Cancer Awareness Foundation to educate men about this disease. Read More ›
Fatigue is a common complaint of people facing cancer that can affect them during and after treatment. Registered Dietitian Julie Lanford provides tips on energy-boosting foods and simple nourishment ideas to help combat fatigue during cancer. Read More ›
“A cancer diagnosis can derail even the best methods of communication,” says oncology social worker Katie Narvarte. She offers tips on how to address difficult topics related to cancer, and how to avoid saying the wrong things. Read More ›
In May 2019, the FDA approved Tibsovo for the treatment of older patients with newly diagnosed acute myeloid leukemia (AML) and an IDH1 mutation, or for patients with AML who are unable to use intensive chemotherapy. Read More ›